Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea
Clinical trial NCT01543451 · COMPLETED
Trial details
- NCT number
- NCT01543451
- Sponsor
- Helsinn Healthcare SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-01-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.